NUDC_HUMAN - dbPTM
NUDC_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NUDC_HUMAN
UniProt AC Q9Y266
Protein Name Nuclear migration protein nudC
Gene Name NUDC
Organism Homo sapiens (Human).
Sequence Length 331
Subcellular Localization Cytoplasm, cytoskeleton. Nucleus. In a filamentous pattern adjacent to the nucleus of migrating cerebellar granule cells. Colocalizes with tubulin and dynein and with the microtubule organizing center. Distributed throughout the cytoplasm of non-migr
Protein Description Plays a role in neurogenesis and neuronal migration (By similarity). Necessary for correct formation of mitotic spindles and chromosome separation during mitosis. Necessary for cytokinesis and cell proliferation..
Protein Sequence MGGEQEEERFDGMLLAMAQQHEGGVQELVNTFFSFLRRKTDFFIGGEEGMAEKLITQTFSHHNQLAQKTRREKRARQEAERREKAERAARLAKEAKSETSGPQIKELTDEEAERLQLEIDQKKDAENHEAQLKNGSLDSPGKQDTEEDEEEDEKDKGKLKPNLGNGADLPNYRWTQTLSELDLAVPFCVNFRLKGKDMVVDIQRRHLRVGLKGQPAIIDGELYNEVKVEESSWLIEDGKVVTVHLEKINKMEWWSRLVSSDPEINTKKINPENSKLSDLDSETRSMVEKMMYDQRQKSMGLPTSDEQKKQEILKKFMDQHPEMDFSKAKFN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
19UbiquitinationGMLLAMAQQHEGGVQ
HHHHHHHHHCCCHHH
31.8821890473
24UbiquitinationMAQQHEGGVQELVNT
HHHHCCCHHHHHHHH
18.2322817900
392-HydroxyisobutyrylationFFSFLRRKTDFFIGG
HHHHHHHCCCEECCC
46.11-
39AcetylationFFSFLRRKTDFFIGG
HHHHHHHCCCEECCC
46.1162135805
39UbiquitinationFFSFLRRKTDFFIGG
HHHHHHHCCCEECCC
46.11-
40PhosphorylationFSFLRRKTDFFIGGE
HHHHHHCCCEECCCC
35.91-
47UbiquitinationTDFFIGGEEGMAEKL
CCEECCCCCCHHHHH
46.2824816145
50SulfoxidationFIGGEEGMAEKLITQ
ECCCCCCHHHHHHHH
5.0121406390
53UbiquitinationGEEGMAEKLITQTFS
CCCCHHHHHHHHHHH
35.3329967540
56UbiquitinationGMAEKLITQTFSHHN
CHHHHHHHHHHHHHH
31.8022817900
58PhosphorylationAEKLITQTFSHHNQL
HHHHHHHHHHHHHHH
20.6028857561
60PhosphorylationKLITQTFSHHNQLAQ
HHHHHHHHHHHHHHH
27.5028857561
682-HydroxyisobutyrylationHHNQLAQKTRREKRA
HHHHHHHHHHHHHHH
38.09-
68AcetylationHHNQLAQKTRREKRA
HHHHHHHHHHHHHHH
38.0925953088
68UbiquitinationHHNQLAQKTRREKRA
HHHHHHHHHHHHHHH
38.0921906983
72UbiquitinationLAQKTRREKRARQEA
HHHHHHHHHHHHHHH
43.5321890473
73UbiquitinationAQKTRREKRARQEAE
HHHHHHHHHHHHHHH
49.9322817900
74UbiquitinationQKTRREKRARQEAER
HHHHHHHHHHHHHHH
30.1922817900
76UbiquitinationTRREKRARQEAERRE
HHHHHHHHHHHHHHH
38.6221890473
77UbiquitinationRREKRARQEAERREK
HHHHHHHHHHHHHHH
53.9522817900
81UbiquitinationRARQEAERREKAERA
HHHHHHHHHHHHHHH
60.1422817900
93AcetylationERAARLAKEAKSETS
HHHHHHHHHHHHCCC
63.9011921613
96SumoylationARLAKEAKSETSGPQ
HHHHHHHHHCCCCCC
50.33-
96SumoylationARLAKEAKSETSGPQ
HHHHHHHHHCCCCCC
50.33-
96UbiquitinationARLAKEAKSETSGPQ
HHHHHHHHHCCCCCC
50.3333845483
97PhosphorylationRLAKEAKSETSGPQI
HHHHHHHHCCCCCCH
53.8328985074
99PhosphorylationAKEAKSETSGPQIKE
HHHHHHCCCCCCHHH
46.1825262027
100PhosphorylationKEAKSETSGPQIKEL
HHHHHCCCCCCHHHC
44.4125627689
100UbiquitinationKEAKSETSGPQIKEL
HHHHHCCCCCCHHHC
44.4124816145
104UbiquitinationSETSGPQIKELTDEE
HCCCCCCHHHCCHHH
4.1624816145
105AcetylationETSGPQIKELTDEEA
CCCCCCHHHCCHHHH
41.2323236377
105UbiquitinationETSGPQIKELTDEEA
CCCCCCHHHCCHHHH
41.2321906983
108PhosphorylationGPQIKELTDEEAERL
CCCHHHCCHHHHHHH
42.3229255136
109UbiquitinationPQIKELTDEEAERLQ
CCHHHCCHHHHHHHH
65.4522817900
113UbiquitinationELTDEEAERLQLEID
HCCHHHHHHHHHHHH
58.1522817900
1222-HydroxyisobutyrylationLQLEIDQKKDAENHE
HHHHHHHHHHHHHHH
49.20-
122AcetylationLQLEIDQKKDAENHE
HHHHHHHHHHHHHHH
49.2025953088
122UbiquitinationLQLEIDQKKDAENHE
HHHHHHHHHHHHHHH
49.2021906983
123UbiquitinationQLEIDQKKDAENHEA
HHHHHHHHHHHHHHH
57.4422817900
125UbiquitinationEIDQKKDAENHEAQL
HHHHHHHHHHHHHHH
28.5021890473
126UbiquitinationIDQKKDAENHEAQLK
HHHHHHHHHHHHHHH
70.0722817900
127UbiquitinationDQKKDAENHEAQLKN
HHHHHHHHHHHHHHC
39.7722817900
129UbiquitinationKKDAENHEAQLKNGS
HHHHHHHHHHHHCCC
50.0921890473
130UbiquitinationKDAENHEAQLKNGSL
HHHHHHHHHHHCCCC
16.6822817900
131UbiquitinationDAENHEAQLKNGSLD
HHHHHHHHHHCCCCC
50.4122817900
133UbiquitinationENHEAQLKNGSLDSP
HHHHHHHHCCCCCCC
47.3732015554
134UbiquitinationNHEAQLKNGSLDSPG
HHHHHHHCCCCCCCC
54.6122817900
136PhosphorylationEAQLKNGSLDSPGKQ
HHHHHCCCCCCCCCC
38.1023927012
139PhosphorylationLKNGSLDSPGKQDTE
HHCCCCCCCCCCCCC
40.6229255136
145PhosphorylationDSPGKQDTEEDEEED
CCCCCCCCCCCHHHH
38.4929255136
145UbiquitinationDSPGKQDTEEDEEED
CCCCCCCCCCCHHHH
38.4922817900
147UbiquitinationPGKQDTEEDEEEDEK
CCCCCCCCCHHHHHH
73.2021890473
153UbiquitinationEEDEEEDEKDKGKLK
CCCHHHHHHHCCCCC
67.4524816145
157UbiquitinationEEDEKDKGKLKPNLG
HHHHHHCCCCCCCCC
51.1424816145
160UbiquitinationEKDKGKLKPNLGNGA
HHHCCCCCCCCCCCC
35.03-
162UbiquitinationDKGKLKPNLGNGADL
HCCCCCCCCCCCCCC
60.0222817900
163UbiquitinationKGKLKPNLGNGADLP
CCCCCCCCCCCCCCC
8.3822817900
166UbiquitinationLKPNLGNGADLPNYR
CCCCCCCCCCCCCCC
20.7622817900
172PhosphorylationNGADLPNYRWTQTLS
CCCCCCCCCCCCCHH
12.9426074081
179PhosphorylationYRWTQTLSELDLAVP
CCCCCCHHHHCCCCC
39.2328348404
179UbiquitinationYRWTQTLSELDLAVP
CCCCCCHHHHCCCCC
39.2322817900
180UbiquitinationRWTQTLSELDLAVPF
CCCCCHHHHCCCCCE
49.7922817900
183UbiquitinationQTLSELDLAVPFCVN
CCHHHHCCCCCEEEE
8.9422817900
184UbiquitinationTLSELDLAVPFCVNF
CHHHHCCCCCEEEEE
13.4522817900
194AcetylationFCVNFRLKGKDMVVD
EEEEEEECCCCEEEE
60.7123749302
194UbiquitinationFCVNFRLKGKDMVVD
EEEEEEECCCCEEEE
60.7122817900
1962-HydroxyisobutyrylationVNFRLKGKDMVVDIQ
EEEEECCCCEEEEHH
40.85-
196AcetylationVNFRLKGKDMVVDIQ
EEEEECCCCEEEEHH
40.8523749302
196UbiquitinationVNFRLKGKDMVVDIQ
EEEEECCCCEEEEHH
40.8521906983
198SulfoxidationFRLKGKDMVVDIQRR
EEECCCCEEEEHHHH
3.4521406390
198UbiquitinationFRLKGKDMVVDIQRR
EEECCCCEEEEHHHH
3.4522817900
200UbiquitinationLKGKDMVVDIQRRHL
ECCCCEEEEHHHHHH
4.2721890473
202UbiquitinationGKDMVVDIQRRHLRV
CCCEEEEHHHHHHHC
2.0122817900
204UbiquitinationDMVVDIQRRHLRVGL
CEEEEHHHHHHHCCC
28.4621890473
212UbiquitinationRHLRVGLKGQPAIID
HHHHCCCCCCCEEEC
49.9621906983
216UbiquitinationVGLKGQPAIIDGELY
CCCCCCCEEECCEEE
11.9522817900
218UbiquitinationLKGQPAIIDGELYNE
CCCCCEEECCEEECE
6.3822817900
219UbiquitinationKGQPAIIDGELYNEV
CCCCEEECCEEECEE
38.1022817900
220UbiquitinationGQPAIIDGELYNEVK
CCCEEECCEEECEEE
19.1922817900
223PhosphorylationAIIDGELYNEVKVEE
EEECCEEECEEEEEE
12.6520068231
226UbiquitinationDGELYNEVKVEESSW
CCEEECEEEEEECEE
8.1921890473
231PhosphorylationNEVKVEESSWLIEDG
CEEEEEECEEEEECC
17.2024905233
232PhosphorylationEVKVEESSWLIEDGK
EEEEEECEEEEECCE
29.2224905233
239AcetylationSWLIEDGKVVTVHLE
EEEEECCEEEEEEEE
45.9419608861
239UbiquitinationSWLIEDGKVVTVHLE
EEEEECCEEEEEEEE
45.9432015554
240UbiquitinationWLIEDGKVVTVHLEK
EEEECCEEEEEEEEH
5.5124816145
2472-HydroxyisobutyrylationVVTVHLEKINKMEWW
EEEEEEEHHCCHHHH
58.92-
248UbiquitinationVTVHLEKINKMEWWS
EEEEEEHHCCHHHHH
4.3527667366
250AcetylationVHLEKINKMEWWSRL
EEEEHHCCHHHHHHH
41.4925953088
250UbiquitinationVHLEKINKMEWWSRL
EEEEHHCCHHHHHHH
41.49-
251UbiquitinationHLEKINKMEWWSRLV
EEEHHCCHHHHHHHH
4.5022817900
253UbiquitinationEKINKMEWWSRLVSS
EHHCCHHHHHHHHCC
8.5421890473
255PhosphorylationINKMEWWSRLVSSDP
HCCHHHHHHHHCCCC
19.4627273156
255UbiquitinationINKMEWWSRLVSSDP
HCCHHHHHHHHCCCC
19.4622817900
257UbiquitinationKMEWWSRLVSSDPEI
CHHHHHHHHCCCCCC
3.5021890473
259PhosphorylationEWWSRLVSSDPEINT
HHHHHHHCCCCCCCC
33.3527273156
259UbiquitinationEWWSRLVSSDPEINT
HHHHHHHCCCCCCCC
33.3522817900
260PhosphorylationWWSRLVSSDPEINTK
HHHHHHCCCCCCCCC
50.1023401153
260UbiquitinationWWSRLVSSDPEINTK
HHHHHHCCCCCCCCC
50.1022817900
265UbiquitinationVSSDPEINTKKINPE
HCCCCCCCCCCCCCC
44.1522817900
266PhosphorylationSSDPEINTKKINPEN
CCCCCCCCCCCCCCC
39.1023186163
266UbiquitinationSSDPEINTKKINPEN
CCCCCCCCCCCCCCC
39.1021890473
2672-HydroxyisobutyrylationSDPEINTKKINPENS
CCCCCCCCCCCCCCC
47.36-
267AcetylationSDPEINTKKINPENS
CCCCCCCCCCCCCCC
47.3625953088
267UbiquitinationSDPEINTKKINPENS
CCCCCCCCCCCCCCC
47.3621906983
268AcetylationDPEINTKKINPENSK
CCCCCCCCCCCCCCC
45.7525953088
268UbiquitinationDPEINTKKINPENSK
CCCCCCCCCCCCCCC
45.7522817900
269UbiquitinationPEINTKKINPENSKL
CCCCCCCCCCCCCCC
12.7022817900
271UbiquitinationINTKKINPENSKLSD
CCCCCCCCCCCCCCC
45.6922817900
272UbiquitinationNTKKINPENSKLSDL
CCCCCCCCCCCCCCC
70.4222817900
273UbiquitinationTKKINPENSKLSDLD
CCCCCCCCCCCCCCC
45.7822817900
274PhosphorylationKKINPENSKLSDLDS
CCCCCCCCCCCCCCH
33.0629255136
275AcetylationKINPENSKLSDLDSE
CCCCCCCCCCCCCHH
64.6923236377
275UbiquitinationKINPENSKLSDLDSE
CCCCCCCCCCCCCHH
64.6923000965
276UbiquitinationINPENSKLSDLDSET
CCCCCCCCCCCCHHH
4.9022817900
277PhosphorylationNPENSKLSDLDSETR
CCCCCCCCCCCHHHH
39.6029255136
278UbiquitinationPENSKLSDLDSETRS
CCCCCCCCCCHHHHH
66.0022505724
279UbiquitinationENSKLSDLDSETRSM
CCCCCCCCCHHHHHH
7.5821890473
281PhosphorylationSKLSDLDSETRSMVE
CCCCCCCHHHHHHHH
48.4429255136
283PhosphorylationLSDLDSETRSMVEKM
CCCCCHHHHHHHHHH
31.8129255136
283UbiquitinationLSDLDSETRSMVEKM
CCCCCHHHHHHHHHH
31.8121890473
285PhosphorylationDLDSETRSMVEKMMY
CCCHHHHHHHHHHHH
34.3025159151
2892-HydroxyisobutyrylationETRSMVEKMMYDQRQ
HHHHHHHHHHHHHHH
19.98-
289UbiquitinationETRSMVEKMMYDQRQ
HHHHHHHHHHHHHHH
19.9824816145
292PhosphorylationSMVEKMMYDQRQKSM
HHHHHHHHHHHHHHC
12.86-
293UbiquitinationMVEKMMYDQRQKSMG
HHHHHHHHHHHHHCC
21.2024816145
297UbiquitinationMMYDQRQKSMGLPTS
HHHHHHHHHCCCCCC
44.6027667366
298PhosphorylationMYDQRQKSMGLPTSD
HHHHHHHHCCCCCCH
15.1125159151
299SulfoxidationYDQRQKSMGLPTSDE
HHHHHHHCCCCCCHH
9.1221406390
301UbiquitinationQRQKSMGLPTSDEQK
HHHHHCCCCCCHHHH
2.9127667366
303PhosphorylationQKSMGLPTSDEQKKQ
HHHCCCCCCHHHHHH
54.5824114839
304PhosphorylationKSMGLPTSDEQKKQE
HHCCCCCCHHHHHHH
36.8925159151
305UbiquitinationSMGLPTSDEQKKQEI
HCCCCCCHHHHHHHH
65.9027667366
3082-HydroxyisobutyrylationLPTSDEQKKQEILKK
CCCCHHHHHHHHHHH
55.14-
308UbiquitinationLPTSDEQKKQEILKK
CCCCHHHHHHHHHHH
55.1421906983
309UbiquitinationPTSDEQKKQEILKKF
CCCHHHHHHHHHHHH
53.5122817900
312UbiquitinationDEQKKQEILKKFMDQ
HHHHHHHHHHHHHHH
6.7322817900
313UbiquitinationEQKKQEILKKFMDQH
HHHHHHHHHHHHHHC
4.9322817900
314UbiquitinationQKKQEILKKFMDQHP
HHHHHHHHHHHHHCC
50.0222817900
315AcetylationKKQEILKKFMDQHPE
HHHHHHHHHHHHCCC
42.3425953088
315UbiquitinationKKQEILKKFMDQHPE
HHHHHHHHHHHHCCC
42.3421906983
316UbiquitinationKQEILKKFMDQHPEM
HHHHHHHHHHHCCCC
6.6222817900
317SulfoxidationQEILKKFMDQHPEMD
HHHHHHHHHHCCCCC
7.1421406390
317UbiquitinationQEILKKFMDQHPEMD
HHHHHHHHHHCCCCC
7.1422817900
318UbiquitinationEILKKFMDQHPEMDF
HHHHHHHHHCCCCCH
46.9322817900
319UbiquitinationILKKFMDQHPEMDFS
HHHHHHHHCCCCCHH
42.1021890473
322UbiquitinationKFMDQHPEMDFSKAK
HHHHHCCCCCHHHHC
49.6222817900
323SulfoxidationFMDQHPEMDFSKAKF
HHHHCCCCCHHHHCC
8.1030846556
323UbiquitinationFMDQHPEMDFSKAKF
HHHHCCCCCHHHHCC
8.1021890473
324UbiquitinationMDQHPEMDFSKAKFN
HHHCCCCCHHHHCCC
42.9022817900
325UbiquitinationDQHPEMDFSKAKFN-
HHCCCCCHHHHCCC-
8.5622817900
326PhosphorylationQHPEMDFSKAKFN--
HCCCCCHHHHCCC--
27.6919060867
3272-HydroxyisobutyrylationHPEMDFSKAKFN---
CCCCCHHHHCCC---
56.44-
327AcetylationHPEMDFSKAKFN---
CCCCCHHHHCCC---
56.4425953088
327MethylationHPEMDFSKAKFN---
CCCCCHHHHCCC---
56.4442360665
327UbiquitinationHPEMDFSKAKFN---
CCCCCHHHHCCC---
56.4421906983
328UbiquitinationPEMDFSKAKFN----
CCCCHHHHCCC----
22.0722817900
329MethylationEMDFSKAKFN-----
CCCHHHHCCC-----
49.53115974295
329UbiquitinationEMDFSKAKFN-----
CCCHHHHCCC-----
49.5322817900
331UbiquitinationDFSKAKFN-------
CHHHHCCC-------
50.7222505724
332UbiquitinationFSKAKFN--------
HHHHCCC--------
21890473
335UbiquitinationAKFN-----------
HCCC-----------
22505724
336UbiquitinationKFN------------
CCC------------
21890473
346Ubiquitination----------------------
----------------------
24816145
350Ubiquitination--------------------------
--------------------------
24816145
354Ubiquitination------------------------------
------------------------------
27667366
358Ubiquitination----------------------------------
----------------------------------
27667366
365Ubiquitination-----------------------------------------
-----------------------------------------
22817900
366Ubiquitination------------------------------------------
------------------------------------------
22817900
369Ubiquitination---------------------------------------------
---------------------------------------------
22817900
370Ubiquitination----------------------------------------------
----------------------------------------------
22817900
371Ubiquitination-----------------------------------------------
-----------------------------------------------
22817900
372Ubiquitination------------------------------------------------
------------------------------------------------
21890473
375Ubiquitination---------------------------------------------------
---------------------------------------------------
22817900
376Ubiquitination----------------------------------------------------
----------------------------------------------------
21890473
384Ubiquitination------------------------------------------------------------
------------------------------------------------------------
22505724
388Ubiquitination----------------------------------------------------------------
----------------------------------------------------------------
22505724

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
40TPhosphorylationKinaseAURKBQ96GD4
GPS
274SPhosphorylationKinasePLK1P53350
Uniprot
326SPhosphorylationKinasePLK1P53350
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
274SPhosphorylation

12852857
326SPhosphorylation

12852857

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NUDC_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PLK1_HUMANPLK1physical
12852857
LIS1_HUMANPAFAH1B1physical
9601647
LIS1_HUMANPAFAH1B1physical
20675372
HS90A_HUMANHSP90AA1physical
20675372
TRM1_HUMANTRMT1physical
22939629
PPME1_HUMANPPME1physical
22939629
ERF1_HUMANETF1physical
22863883
H33_HUMANH3F3Aphysical
22863883
SYK_HUMANKARSphysical
22863883
PAPOA_HUMANPAPOLAphysical
22863883
TLN1_HUMANTLN1physical
22863883
DNJA2_HUMANDNAJA2physical
25036637
DNJB1_HUMANDNAJB1physical
25036637
MAEL_HUMANMAELphysical
25036637
DNJA1_HUMANDNAJA1physical
25036637
RS17_HUMANRPS17physical
25036637
ADAM9_HUMANADAM9physical
26344197
ICAL_HUMANCASTphysical
26344197
CCDC6_HUMANCCDC6physical
26344197
G3P_HUMANGAPDHphysical
26344197
SODC_HUMANSOD1physical
26344197
EMAL4_HUMANEML4physical
25789526
WDR35_HUMANWDR35physical
27173435
IF172_HUMANIFT172physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NUDC_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-239, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-260 AND SER-281, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139 AND THR-145, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139 AND THR-145, ANDMASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139; THR-145 ANDSER-285, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139 AND THR-145, ANDMASS SPECTROMETRY.
"A role for Plk1 phosphorylation of NudC in cytokinesis.";
Zhou T., Aumais J.P., Liu X., Yu-Lee L.-Y., Erikson R.L.;
Dev. Cell 5:127-138(2003).
Cited for: FUNCTION, INTERACTION WITH PLK1, IDENTIFICATION IN A COMPLEX WITHDYNACTIN AND DYNEIN, MUTAGENESIS OF SER-274 AND SER-326, ANDPHOSPHORYLATION AT SER-274 AND SER-326.

TOP